PubMed=3947514; DOI=10.1038/bjc.1986.6; PMCID=PMC2001479
Durrant L.G., Robins R.A., Pimm M.V., Perkins A.C., Armitage N.C.M., Hardcastle J.D., Baldwin R.W.
Antigenicity of newly established colorectal carcinoma cell lines.
Br. J. Cancer 53:37-45(1986)

PubMed=3435698; DOI=10.1038/bjc.1987.277; PMCID=PMC2002417
Durrant L.G., Garnett M.C., Gallego J., Armitage N.C.M., Ballantyne K.C., Marksman R.A., Hardcastle J.D., Baldwin R.W.
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.
Br. J. Cancer 56:722-726(1987)

PubMed=1846553; DOI=10.1038/bjc.1991.14; PMCID=PMC1971664
Durrant L.G., Watson S.A., Hall A., Morris D.L.
Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I.
Br. J. Cancer 63:67-70(1991)

PubMed=25926053; DOI=10.1038/ncomms8002
Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G., Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S., Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M., Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets.
Nat. Commun. 6:7002.1-7002.10(2015)